The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
Abstract α1‐adrenoceptor antagonists are widely used for hypertension (eg, doxazosin) and benign prostatic hypertrophy (BPH, eg, tamsulosin). Some antidepressants and antipsychotics have been reported to have α1 affinity. This study examined 101 clinical drugs and laboratory compounds to build a com...
Saved in:
Main Authors: | Richard G. W. Proudman (Author), Andre S. Pupo (Author), Jillian G. Baker (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G.W. Proudman, et al.
Published: (2022) -
The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2021) -
The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
by: Richard G. W. Proudman, et al.
Published: (2022) -
α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation
by: Xianlong Gao, et al.
Published: (2023) -
Identification of Cysteine-Rich Epidermal Growth Factor-Like Domain 1α (CRELD1α) as a Novel α1A-Adrenoceptor-Down-Regulating Protein and Establishment of an α1L-Adrenoceptor-Expressing Cell Line
by: Atsushi Nishimune, et al.
Published: (2010)